mRNA Technology - Search News

FDA agrees to evaluate Moderna mRNA flu vaccine

Scientific American · 9d

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Continue reading

FDA reverses course, will review Moderna's mRNA flu vaccine

· 2d · on MSN

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

FDA reverses course on Moderna's flu vaccine

The FDA says it will now review a new m-r-n-a flu vaccine from Moderna.

Continue reading

Moderna got a win from the FDA, but political headwinds remain a concern for vaccine makers

A Welcome FDA Walkback on a Flu Vaccine

Moderna says the FDA will consider its new flu shot after resolving a public dispute

The dispute centered over a 40,000-person clinical trial that concluded Moderna’s new vaccine was more effective in adults aged 50 and older than one of the standard flu shots used today.

Continue reading

State's top health official: FDA's reversal on Moderna's flu vaccine could ‘chill the market’

Moderna Wins Regulatory Reversal as U.S. FDA Agrees to Evaluate New Shot